SundrugSUNDRUG CO.,LTD.9989東証プライム小売業FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥6 is left as operating profit. Revenue changed +5.1% from the prior year, operating profit +5.2%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 3.7% | 1.99× | 7.3% | 1.46× | 10.7% |
| 2023 | 3.7% | 2.01× | 7.5% | 1.49× | 11.2% |
| 2024 | 3.9% | 1.93× | 7.5% | 1.58× | 11.8% |
| 2025 | 3.8% | 1.86× | 7.1% | 1.64× | 11.7% |
| 2026 | 3.7% | 1.83× | 6.8% | 1.65× | 11.2% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 648,734 | 690,462 | 751,777 | 801,811 | 842,512 |
| Cost of revenue | 492,228 | 518,516 | 562,457 | 597,723 | 626,341 |
| Gross profit | 156,506 | 171,946 | 189,319 | 204,087 | 216,170 |
| SG&A | 122,454 | 134,493 | 148,323 | 159,591 | 169,338 |
| Operating income | 34,052 | 37,452 | 40,996 | 44,496 | 46,831 |
| Pretax income | 34,675 | 37,710 | 41,261 | 43,569 | 45,803 |
| Income tax | 10,821 | 12,007 | 12,134 | 12,818 | 14,411 |
| Net income attributable to owners | 23,853 | 25,703 | 29,126 | 30,750 | 31,392 |
| Operating margin | 5.2% | 5.4% | 5.5% | 5.5% | 5.6% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥89.3B | ¥80.9B | ¥69.7B | ¥65B | ¥70.5B |
| Total assets | ¥325.8B | ¥360.7B | ¥420.2B | ¥444B | ¥475.5B |
| Net assets | ¥220.6B | ¥236.3B | ¥253.1B | ¥269.7B | ¥286B |
| Share capital | ¥3.93B | ¥3.93B | ¥3.93B | ¥3.93B | ¥3.93B |
| Property, plant and equipment | ¥77.9B | ¥100.2B | ¥120.5B | ¥136.7B | ¥148.5B |
| Intangible assets excluding goodwill | ¥5.95B | ¥9.1B | ¥9.14B | ¥8.67B | ¥8.1B |
| Goodwill | ¥2M | ¥1.67B | ¥1.56B | ¥1.44B | ¥1.32B |
| Investment securities | ¥296M | ¥334M | ¥35.8B | ¥34B | ¥32.8B |
| Current assets | ¥199.5B | ¥205.9B | ¥208.2B | ¥216.8B | ¥238.1B |
| Current liabilities | ¥96B | ¥113.2B | ¥155.5B | ¥128.5B | ¥134B |
| Short-term borrowings | — | — | ¥35B | ¥1B | ¥1B |
| Long-term borrowings | — | — | — | ¥33.9B | ¥42.1B |
| Total liabilities | ¥105.2B | ¥124.3B | ¥167.1B | ¥174.3B | ¥189.5B |
| Equity attributable to owners of parent | ¥222.6B | ¥238.1B | ¥254.8B | ¥271.4B | ¥287.5B |
| Retained earnings | ¥215.1B | ¥230.7B | ¥247.3B | ¥263.8B | ¥279.9B |
| Treasury stock | -¥3.94B | -¥3.94B | -¥3.89B | -¥3.87B | -¥3.84B |
EDINET (FSA Japan)
有価証券報告書－第63期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第62期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第61期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第60期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第59期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第58期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 50 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.